The Center for Male Reproductive Health

The Center for Male Reproductive Health

Reproductive Medicine Associates of New York is dedicated to providing patients the highest quality care in a compassionate and supportive manner. Helping couples successfully achieve their family-building goals has been RMA of New York’s focus since 2001.

Recognized Among the World's Top Fertility Clinics

Whether patients are seeking a low-tech approach or are in need of high-tech interventions such as genetic screening of embryos, our team of expert reproductive endocrinologists and clinical specialists can diagnose and effectively treat both rare and common cases of male and female factor infertility. RMA of New York also offers egg, sperm, and embryo freezing for both elective and medical indications, and has helped thousands of women, men, and couples preserve their reproductive options. Research breakthroughs and continuous improvement in laboratory processes and patient care protocols has led RMA of New York to be recognized as one of the top IVF centers in the world.

The Mount Sinai Health System

RMA of New York provides expert quality care and serves patients as the Department of Reproductive Endocrinology and Infertility of the Mount Sinai Health System, an integrated system that includes seven hospital campuses and a top-ranked medical school. The Mount Sinai network includes 6,500+ primary and specialty care physicians, 2,000 residents and fellows, 12 free-standing ambulatory surgery centers, and averages 16,350 babies delivered each year. Mount Sinai Hospital is recognized as a Center of Excellence and ranks among the best hospitals in the region for Obstetrics and Gynecology in the U.S. News & World Report.

RMA of New York's physicians also serve on the faculty board as members of the Mount Sinai Icahn School of Medicine and are involved in extensive clinical research to further the science and technologies of reproductive medicine, including collaborating on studies with the Icahn Institute for Genomics and Multiscale Biology. Our team is actively working to advance methods of embryo sequencing to allow further insight in screening for genetic mutations and chromosomal abnormalities so that we can be sure our patients receive one healthy, screened embryo enabling successful gestation and the birth of one healthy baby.